skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radiolabeled porphyrin versus gallium-67 citrate for the detection of human melanoma in athymic mice

Conference ·
OSTI ID:6864198

We performed the biodistribution and imaging studies of /sup 111/In and /sup 67/Ga labeled tetra(4-N-methylpyridyl) porphine, (T4NMPYP), and compared it to that of /sup 67/Ga citrate in athymic mice bearing a human melanoma xenograft. The biodistribution results of both /sup 111/In and /sup 67/Ga labeled T4NMPYP (3, 6, 24, and 48 hours) were similar but differed from that of /sup 67/Ga citrate (48 hours). The optimum tumor uptake of both radiolabeled porphyrins was at 6 hours postinjection and was lower than the tumor uptake of /sup 67/Ga citrate at 48 hours postinjection. Kidney was the only organ showing higher uptake of radiolabeled porphyrin compared to that of /sup 67/Ga citrate. The imaging studies performed with /sup 111/In T4NMPYP and /sup 67/Ga citrate correspond to the biodistribution results. Osteomyelitis present in one mouse showed good localization of /sup 111/In T4NMPYP. 15 refs., 3 figs., 5 tabs.

Research Organization:
Yale Univ., New Haven, CT (USA). School of Medicine
DOE Contract Number:
AC02-78EV04625
OSTI ID:
6864198
Report Number(s):
CONF-870613-1; ON: DE88017251
Resource Relation:
Conference: 34. annual meeting of the Society of Nuclear Medicine, Toronto, Canada, 2 Jun 1987; Other Information: Portions of this document are illegible in microfiche products
Country of Publication:
United States
Language:
English